FDA
The latest news on FDA
Initial study suggested a cancer drug could reverse effects of Alzheimer's in mice.
New survey finds 1 in 7 products still claim an 'SPF' rating of 50 or higher
When disease has spread to the bones
Gene present in 10 percent of NSCLC cases
Blocks process that contributes to abnormal inflammation
Xofigo was fast-tracked for approval and is meant for tumors that have spread to the bones
Blood levels from nighttime dose of sleep aid can remain too high the next morning, agency says
Kidney cancer patients lose with a recent vote preventing access to a promising new treatment drug.
Respiratory disease is the third-leading cause of death in U.S.
But stops short of ban for those younger than 18, as advisory panel had recommended
